Engineers Gate Manager’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Engineers Gate Manager’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-141	Closed	-$18K	–	2044
2019 Q4	$18K	Hold	141	–	–	﹤0.01%	1584
2019 Q3	$17K	Sell	141 -13	-8%	-$2.62K	﹤0.01%	1341
2019 Q2	$46K	Buy	+154	New	+$64.2K	﹤0.01%	1094
2019 Q1	–	Sell	-233	Closed	-$106K	–	1221
2018 Q4	$106K	Buy	+233	New	+$144K	0.01%	804

Other funds holding HTGM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Engineers Gate Manager's HTGM Position: Q1 2020 in Review

Engineers Gate Manager sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q1 2020, closing a stake of 141 shares — an estimated $18K sold.

Engineers Gate Manager first reported a position in HTGM in Q4 2018 and held it in 4 quarters. The position peaked at $106K in Q4 2018. 33 funds tracked by Wall St. Rank hold HTGM as of Q1 2020.

Engineers Gate Manager reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Engineers Gate Manager sold 141 HTG Molecular Diagnostics, Inc. Common Stock shares in Q1 2020, an estimated $18K.
Engineers Gate Manager first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
Engineers Gate Manager's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $106K in Q4 2018.
33 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q1 2020.

Based on Engineers Gate Manager's 13F filing for Q1 2020, filed 15 May 2020.